- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02473588
Long Time Interval Analysis for Non Invasive Measurement of Cardiac Output
June 12, 2015 updated by: Robert Thiele, MD, University of Virginia
Comparison of Retia Medical (Long Time Interval Analysis) to Deltex Esophageal Doppler for Cardiac Output Measurement
A group of engineers at Michigan State developed a novel waveform analysis technique ("Long Time Interval Analysis" [LTIA]) that attempts to estimate cardiac output non-invasively.
Retrospective comparison of LTIA to invasive techniques (e.g.
thermodilution) suggest acceptable agreement.
Thus, a prospective trial of LTIA is warranted.
This study compares LTIA to a validated measure of cardiac output - esophageal Doppler monitoring.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- Recruiting
- University of Virginia Health System
-
Contact:
- Robert H Thiele, M.D.
- Phone Number: 434-243-9412
- Email: rht7w@virginia.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult (18 years or older)
- Undergoing hepatobiliary surgery (open or laparoscopic) requiring general anesthesia as part of the patient's clinical care
- Attending anesthesiologist plans to place an intra-arterial catheter for routine care
- Attending anesthesiologist believes that non-invasive cardiac output monitoring would benefit the patient
Exclusion Criteria:
- Minors (17 years or younger)
- Parturient (pregnant women)
- Cognitively impaired
- Unable to sign informed consent form
- Prisoner
- Prior esophageal surgery
- Moderate to severe aortic regurgitation
- Mechanical cardiac support (e.g., intra-aortic balloon pump)
- Severe, persistent arrhythmias
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: LTIA Group
Patients in the LTIA Group (all patients) will have blood pressure recorded continuously.
LTIA will be used to measure stroke volume and cardiac output after the completion of data collection
|
Retia Medical "Long Time Interval Analysis" will be used to analyze the blood pressure tracing of patients having surgery who have an arterial catheter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pearson Correlation Coefficient
Time Frame: Data collected in first 20 minutes of anesthesia/surgery will be recorded; Pearson correlation coefficient will be calculated after all 60 subjects have been enrolled
|
Correlation between change in CO from LTIA vs. change in CO from esophageal Doppler
|
Data collected in first 20 minutes of anesthesia/surgery will be recorded; Pearson correlation coefficient will be calculated after all 60 subjects have been enrolled
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Anticipated)
November 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
June 11, 2015
First Submitted That Met QC Criteria
June 12, 2015
First Posted (Estimate)
June 16, 2015
Study Record Updates
Last Update Posted (Estimate)
June 16, 2015
Last Update Submitted That Met QC Criteria
June 12, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypotension
-
Bradley MarinoNot yet recruitingHypotension During Surgery | Hypotension PostproceduralUnited States
-
University Medical Centre LjubljanaNot yet recruitingOrthostatic Hypotension | Postprandial HypotensionSlovenia
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Edwards LifesciencesCompletedHypotension | Intraoperative Hypotension | Postoperative HypotensionNetherlands
-
James J. Peters Veterans Affairs Medical CenterCompleted
-
Aretaieion University HospitalNot yet recruitingHypotension After Spinal Anesthesia | Hypotension During Cesarean Delivery
-
Universitätsklinikum Hamburg-EppendorfRecruitingPostinduction HypotensionGermany
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingHypotension Drug-Induced | Hypotension During Surgery
-
Attikon HospitalCompletedHypotension During Surgery | Prevention of HypotensionGreece
-
Universitätsklinikum Hamburg-EppendorfCompletedBlood Pressure | Postinduction Hypotension | Perioperative HypotensionGermany
-
Peking Union Medical College HospitalRecruitingPost-induction Hypotension | Postprandial HypotensionChina
Clinical Trials on Retia Medical Long Time Interval Analysis
-
Sheba Medical CenterRecruitingGlaucoma | Glaucoma; DrugsIsrael
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma (Skin)United States
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI)Completed
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Peritoneal Carcinomatosis | Gastroesophageal Junction AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Gastric Adenocarcinoma | Clinical Stage IVB Gastric Cancer AJCC v8 | Metastatic Malignant Neoplasm in the PeritoneumUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Malignant Neoplasm in the PeritoneumUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNektar TherapeuticsActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent Grade 3b Follicular Lymphoma | Refractory Grade 3b Follicular... and other conditionsUnited States